Back to the main directory
Company Analysis / Equity
- Raw material headwinds persist for Coatings companies by Atlantic Equities
- Monash Trading Update Highlights Impact of One-Off Costs and Focus on Premium Service Offering by Morningstar
- Event update: Dish TV India (Outperformer) - Turbulence ahead of the merger? by IDFC Securities
- Infosys' Q3FY18 results (Outperformer) - Inline quarter. Constructive BFSI outlook by IDFC Securities
- 4imprint Group - Strong Q4, US tax change gains by Edison Investment Research
- Merger completes; synergies to drive acceleration by Atlantic Equities
- Aures group: playing in the big league by MidCap Partners
- Improvement but No Quick Fix for Pearson in 2017 by Morningstar
- PSA Today Jan 17: Market off on yen strength, Bitcoin slide/TDK/Soliton's Olympics advantage/The cosme space/Subaru in the US/LINE and iPASS - Nikkei -0.35% by Pelham Smithers Associates Ltd
- Rio Tinto Dividends Likely Rise with 2017 Result, but Shares Remain Overvalued by Morningstar
- Mortgage Choice’s Growth Prospects Moderate but Remain Attractive; AUD 2.50 FVE Unchanged by Morningstar
- Sirtex Trading Update Positive, but Flat Dose Sales Anchor Our View; Maintaining AUD 15.50 FVE by Morningstar
- MCB: In the catbird seat, (AKD Insight, Jan 16, 2018) by AKD Securities Limited
- MOSL: LARSEN & TOUBRO (Buy)-The Monitorable Troika-Order inflow, domestic execution and working capital are key by Motilal Oswal
- MOSL: HEALTHCARE- IPM – growth picks up on higher volumes by Motilal Oswal
- Media reports CELG in talks to buy JUNO by Atlantic Equities
- Standard Life Equity Income Trust - Unconstrained approach to UK equity investing by Edison Investment Research
- Q4 snap: lower tax rate assists modest beat by Atlantic Equities
- 4Q Snap: EPS beat mainly due to lower tax rate by Atlantic Equities
- Tiffany Holiday Sales Solid, but Future Growth Requires Investment; We Increase FVE to $88 by Morningstar
- New CEO Named by Great Lakes Review, a division of Wellington Shields & Co. LLC
- Exelixis' Pivotal Liver Cancer Results Don't Knock It Out of the Ballpark; $28.50 FVE Unchanged by Morningstar
- Initiating Coverage of Conmed Corp With No-Moat and Stable Trend; Shares Fairly Valued by Morningstar
- One-Time Legal Charge Hurts Otherwise Decent Quarter for U.S. Bancorp; Maintaining Our FVE by Morningstar
- Baxter's margin expansion potential supports healthy earnings growth outlook. by Morningstar